Photo: FS Productions/Blend Images/Getty Images
NeueHealth, a company that connects providers and payers with technology to enable value-based care, closed its previously announced merger by an affiliate of New Enterprise Associates (NEA) at an enterprise value of approximately $1.465 billion, a $165 million increase from its initially projected price in January.
Finalization of the acquisition sees NeueHealth's stock [NYSE: NEUE] delisted from the New York Stock Exchange as of Oct. 2. The stock was last trading at $6.75 per share.
Holders of NeueHealth's common stock will receive $7.33 per share, while certain stockholders, including NEA and 12 other existing investors, have signed rollover agreements where their investments will be exchanged for equity in the now privately held company.
The company says NeueHealth’s executive leadership will continue in their roles and have agreed to roll over 100% of their interests for newly issued equity interests in the private company.
"Since our founding, NeueHealth has been committed to aligning the interests of consumers, payors, and providers to create a seamless, more coordinated care experience for all," Mike Mikan, president and CEO of NeueHealth, said in a statement.
"This transaction marks a significant milestone for our company as it allows us the flexibility and resources to continue to fulfill this mission as we advance our value-driven, consumer-centric care model and drive long-term, sustainable growth into the future."
THE LARGER TREND
In January, NeueHealth announced it had entered into a definitive merger agreement to be acquired by an affiliate of NEA at a value of $1.3 billion.
The company reported its 2025 second-quarter earnings in August, noting revenue of $209,082 compared to $225,991 in the same period last year.
The company reported a net loss of $1,548 in the second quarter compared to a loss of $57,698 the year prior, and adjusted EBITDA of $19,020 in Q2 2025 compared to $3,962 in Q2 2024.
